Barcelona Science Park and Werfen organize an event to present NEB.

For almost 50 years, NEB has been a world leader in the discovery and production of reagents for the life science industry. New England Biolab’s enzymology expertise allows us to supply reagents for synthesis of high-quality RNA – form template generation to transcription, to capping, tailing and clean up after the synthesis.

The use of in vitro synthesized RNA has been instrumental in the development of RNA vaccines, and CRISP/Cas9 genome editing tools, generation of pluripotent stem cells, screening of RNA inhibitors, as well as development of RNA amplification-based diagnostics. All these applications require high-yield robust reactions with optimized reaction components.

In this seminar Werfen presents how NEB’s portfolio supports your high-quality (m)RNA synthesis from bench-scale to commercial-scale and enables a seamless transition from research to therapeutic manufacturing.

9.30-9.35 Welcome

Grisha Domakowski, Commercialization and Communication Director, PCB

9.35-10.30

High Yield RNA synthesis from research to production scale, Marc Davies, PhD, Customized Solutions Business Development Manager for Europe

10.30-10.45 Q&A session

10.45-11:30 Coffee Networking

About the speaker

Marc Davies has an extensive experience within the context of academic research having completed both a four year PhD and two year Post Doctoral research project in the field of virology. He joined New England Biolabs (NEB) in 2012 as a Technical Account Manager and gained extensive scientific, technical and relationship-management experience in a customer-focussed role. In 2020 Marc became a Customized Solutions Business Development Manager for Europe. The knowledge gained during his time in the sales role has been supplemented with experience of business to business interactions to provide comprehensive support for customers wanting custom reagents for their R&D and commercialisation.

High Yield RNA synthesis: from research to production scale